Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Keratosis, Actinic 2Bowen's Disease 1

Interventions

Cyclophosphamide 1492Cisplatin 1413Paclitaxel 1316Radiotherapy 1261Carboplatin 1249Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700Etoposide 678pembrolizumab 677Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Interventional × SR-T100 × Clear all
NCT01516515 2018-12-05

Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic Keratosis

G&E Herbal Biotechnology Co., LTD

Phase 2 Completed
86 enrolled
Dermatologic

Keratosis, Actinic

NCT02085395 2014-03-14

AK

G&E Herbal Biotechnology Co., LTD

Phase 2 Completed
27 enrolled
Dermatologic

Bowen's Disease, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡